When applied to pharmaceuticals, the term “off-label” suggests the (frequently discovered) practical and beneficial uses for a drug that are different from the one it was originally developed for.
It has been long known that complementary metal-oxide semiconductor (CMOS) transistors suffer from a scaling issue. As CMOS field-effect transistors (FETs) get smaller, they become less power ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results